Orthobond Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $5.5M

  • Investors
  • 3

Orthobond General Information

Description

Developer of antimicrobial surface treatments designed to offer antimicrobial nanosurfaces for medical devices. The company's antimicrobial nanosurfaces reduce microbial contamination of medical-grade surfaces by killing a wide range of microorganisms that are commonly found at the site of infected medical devices, enabling healthcare providers to reduce the chance and risk of infection via microbial contamination.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Deerpark Drive
  • Suite A
  • Monmouth Junction, NJ 08852
  • United States
+1 (848)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Other Materials
Corporate Office
  • 1 Deerpark Drive
  • Suite A
  • Monmouth Junction, NJ 08852
  • United States
+1 (848)

Orthobond Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthobond Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jun-2024 $5.5M Completed Generating Revenue
5. Grant 15-Apr-2022 Completed Generating Revenue
4. Later Stage VC (Series B) 16-Oct-2020 Completed Generating Revenue
3. Later Stage VC (Series A) 20-Oct-2011 Completed Generating Revenue
2. Angel (individual) 07-Jun-2005 $3M $3M Completed Product Development
1. University Spin-Out 01-Jan-2004 Completed Startup
To view Orthobond’s complete valuation and funding history, request access »

Orthobond Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-2
Series B-1
Series A 11,700,723 $0.001000 $1.67 $1.67 1x $1.67 26.83%
To view Orthobond’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Orthobond Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antimicrobial surface treatments designed to offer antimicrobial nanosurfaces for medical devices. The comp
Other Devices and Supplies
Monmouth Junction, NJ
19 As of 2024

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orthobond Competitors (1)

One of Orthobond’s competitors is Bactiguard, a Formerly VC-backed company based in Stockholm, Sweden.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bactiguard Formerly VC-backed Stockholm, Sweden
You’re viewing 1 of 1 competitors. Get the full list »

Orthobond Patents

Orthobond Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220266296-A1 Methods of photografting to surface metal oxides Inactive 23-Feb-2021
US-20230284629-A1 Antimicrobial and antiviral treatments of materials Pending 28-Sep-2020
AU-2017346582-A1 Surfaces with oligomeric or polymeric antimicrobials Active 17-Oct-2016
AU-2017346582-B2 Surfaces with oligomeric or polymeric antimicrobials Active 17-Oct-2016
CA-3044464-A1 Surfaces with oligomeric or polymeric antimicrobials Pending 17-Oct-2016 A01N57/16
To view Orthobond’s complete patent history, request access »

Orthobond Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orthobond Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Kineticos Life Sciences Management PE/Buyout Minority
Stephen Kosslyn Angel (individual) Minority
To view Orthobond’s complete investors history, request access »

Orthobond FAQs

  • When was Orthobond founded?

    Orthobond was founded in 2004.

  • Where is Orthobond headquartered?

    Orthobond is headquartered in Monmouth Junction, NJ.

  • What is the size of Orthobond?

    Orthobond has 19 total employees.

  • What industry is Orthobond in?

    Orthobond’s primary industry is Other Devices and Supplies.

  • Is Orthobond a private or public company?

    Orthobond is a Private company.

  • What is Orthobond’s current revenue?

    The current revenue for Orthobond is .

  • How much funding has Orthobond raised over time?

    Orthobond has raised $25.1M.

  • Who are Orthobond’s investors?

    National Institutes of Health, Kineticos Life Sciences Management, and Stephen Kosslyn have invested in Orthobond.

  • Who are Orthobond’s competitors?

    Bactiguard is a competitor of Orthobond.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »